Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
61-75 of 4313 results
Xenetic Biosciences partners with Excivion to develop novel combined Zika and Dengue vaccine
Xenetic Biosciences has commenced a collaboration with Excivion to develop a vaccine against Zika and dengue viruses.
Drug Research > Drug Discovery & Development > News
Caribou Biosciences develops new method to profile CRISPR-Cas9 gene editing outcomes
Caribou Biosciences announced that members of its scientific team have discovered that DNA repair outcomes following Cas9 cleavage of DNA are nonrandom and follow highly reproducible patterns for each target site.
Drug Research > Drug Discovery & Development > News
Study suggests Zika virus may damage adult brain
By PBR Staff Writer
A new study has indicated the Zika virus, which is known to affect unborn babies, may also damage adult brain cells.
Drug Research > Drug Discovery & Development > News
Tioma Therapeutics raises $86m to further develop antibody portfolio
By PBR Staff Writer
Tioma Therapeutics, a venture-stage biopharmaceutical firm focused on the development of anti-CD47 antibodies to treat solid and hematologic cancers, has raised $86m in Series A venture financing.
Drug Research > Drug Discovery & Development > News
NeuroVive Pharmaceutical completes 10% acquisition of Isomerase Therapeutics
NeuroVive Pharmaceutical has completed the second step in the previously announced partial acquisition of the British drug discovery and development company Isomerase Therapeutics.
Drug Research > Drug Discovery & Development > News
Arrowhead Pharmaceuticals closes $45m private offering
Arrowhead Pharmaceuticals (ARWR) has closed a previously announced private offering with a select group of investors that include Orbimed, RA Capital Management, Perceptive Advisors, RTW Investments and other institutional investors.
Drug Research > Drug Discovery & Development > News
Mallinckrodt To Acquire Stratatech
Mallinckrodt has entered into a merger agreement with Stratatech, a privately held regenerative medicine company focused on the development of unique, proprietary skin substitute products.
Drug Research > Drug Discovery & Development > News
AstraZeneca invests another $140m in Moderna Therapeutics
By PBR Staff Writer
AstraZeneca has invested another $140m in Moderna Therapeutics, a US-based biotechnology company focused on the research and development of protein therapies based on novel messenger RNA (mRNA) technology.
Drug Research > Drug Discovery & Development > News
Scintilla Pharmaceuticals enters into binding term sheet to buy SCILEX Pharmaceuticals
Scintilla Pharmaceuticals, a subsidiary of Sorrento Therapeutics, has entered into a binding term sheet to acquire SCILEX Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Helsinn partners with MEI Pharma to develop Pracinostat cancer drug
By PBR Staff Writer
Helsinn has agreed to develop and commercialize MEI Pharma’s Pracinostat drug candidate for acute myeloid leukemia (AML) and other potential indications.
Drug Research > Drug Discovery & Development > News
ScinoPharm, CVie Therapeutics to jointly develop new heart failure drug
ScinoPharm Taiwan and CVie Therapeutics have started a discovery and development collaboration to identify the new generation compound to Istaroxime, CVie’s acute heart failure treatment currently in late Phase IIb trials in Italy and China.
Drug Research > Drug Discovery & Development > News
Clinical stage biotechnology firm Ambrx closes $45m round of financing
Ambrx, a clinical stage biotechnology company that discovers and develops first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates, has closed a $45m round of financing led by Apricot Capital and Northeast Securities Prosperity Healthcare Fund.
Drug Research > Drug Discovery & Development > News
AvroBio raises $25m funding to advance clinical-stage gene therapies for rare diseases
AVROBIO, a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare diseases and cancer, has raised $25m in a Series A financing co-led by Atlas Venture, Clarus and SV Life Sciences.
Drug Research > Drug Discovery & Development > News
Regeneron, Adicet Bio partner to discover next-generation engineered immune cell therapeutics
Regeneron Pharmaceuticals and Adicet Bio announced a collaboration and licensing agreement to develop next-generation engineered immune cell therapeutics.
Drug Research > Drug Discovery & Development > News
Pfizer acquires gene therapy developer Bamboo Therapeutics
By PBR Staff Writer
Pfizer has acquired privately held gene therapy developer Bamboo Therapeutics in a deal worth up to $645m.
Drug Research > Drug Discovery & Development > News
61-75 of 4313 results